Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of elastic recoil by urapidil in coronary stent implantation
2007-003026-14Phase 2Completed
- Sponsor
- Klinik Landstraße
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of urapidil in coronary arteriosclerosis and coronary stenosis, sponsored by Klinik Landstraße. Primary endpoint: Left ventricular ejection fraction at 180 days. Started May 2008; status: completed.
02
Drugs
urapidil
03
Conditions
coronary arteriosclerosiscoronary stenosis
Beyond the preview
Go deeper on 2007-003026-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003026-14.